These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2299874)

  • 1. Heterogeneous delivery of cardioplegic solution in the absence of coronary artery disease.
    Aldea GS; Austin RE; Flynn AE; Coggins DL; Husseini W; Hoffman JI
    J Thorac Cardiovasc Surg; 1990 Feb; 99(2):345-53. PubMed ID: 2299874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial protection in the failing heart: II. Effect of pulsatile cardioplegic perfusion under simulated left ventricular restoration.
    Kassab GS; Kostelec M; Buckberg GD; Covell J; Sadeghi A; Hoffman JI
    J Thorac Cardiovasc Surg; 2006 Oct; 132(4):884-90. PubMed ID: 17000301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of retrograde cardioplegia. I. Capillary blood flow distribution to myocardium supplied by open and occluded arteries.
    Partington MT; Acar C; Buckberg GD; Julia P; Kofsky ER; Bugyi HI
    J Thorac Cardiovasc Surg; 1989 Apr; 97(4):605-12. PubMed ID: 2927164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of cardioplegic solution infused antegradely and retrogradely in normal canine hearts.
    Stirling MC; McClanahan TB; Schott RJ; Lynch MJ; Bolling SF; Kirsh MM; Gallagher KP
    J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1066-76. PubMed ID: 2586122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical and mechanical effects of cardioplegic injection on flow distribution and myocardial damage in hearts with normal coronary arteries.
    Molina JE; Galliani CA; Einzig S; Bianco R; Rasmussen T; Clack R
    J Thorac Cardiovasc Surg; 1989 Jun; 97(6):870-7. PubMed ID: 2542693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation.
    Okada K; Yamashita C; Okada M; Okada M
    J Heart Lung Transplant; 1996 May; 15(5):475-84. PubMed ID: 8771503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biventricular distribution of cold blood cardioplegic solution administered by different retrograde techniques.
    Crooke GA; Harris LH; Grossi EA; Baumann FG; Galloway AC; Colvin SB
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):631-7; discussion 637-8. PubMed ID: 1921440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of retrograde cardioplegia. II. Advantages of antegrade/retrograde cardioplegia to optimize distribution in jeopardized myocardium.
    Partington MT; Acar C; Buckberg GD; Julia PL
    J Thorac Cardiovasc Surg; 1989 Apr; 97(4):613-22. PubMed ID: 2927165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial protection in the failing heart: I. Effect of cardioplegia and the beating state under simulated left ventricular restoration.
    Kostelec M; Covell J; Buckberg GD; Sadeghi A; Hoffman JI; Kassab GS
    J Thorac Cardiovasc Surg; 2006 Oct; 132(4):875-83. PubMed ID: 17000300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardioprotective effects of cariporide as an adjunct in different cardioplegic solutions: an experiment with rabbits].
    Zhou RH; Long C; Liu J; Liu B
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2320-3. PubMed ID: 18036293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioplegic infusion: the safe limits of pressure and temperature.
    Johnson RE; Dorsey LM; Moye SJ; Hatcher CR; Guyton RA
    J Thorac Cardiovasc Surg; 1982 Jun; 83(6):813-24. PubMed ID: 7087508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the effects of hypothermia on regional myocardial blood flow and metabolism during cardiopulmonary bypass. III. Effects of temperature, time, and perfusion pressure in fibrillating hearts.
    Brazier JR; Cooper N; McConnell DH; Buckberg GD
    J Thorac Cardiovasc Surg; 1977 Jan; 73(1):102-9. PubMed ID: 830999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart.
    Greenfield DT; Greenfield LJ; Hess ML
    J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal intraoperative protection of myocardium distal to coronary stenoses.
    Silverman NA; Schmitt G; Levitsky S; Feinberg H
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):424-31. PubMed ID: 6433111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of amino acids on the ischemic heart. Improvement of oxygenated crystalloid cardioplegic solution by an enriched branched chain amino acid formulation.
    Schwalb H; Izhar U; Yaroslavsky E; Borman JB; Uretzky G
    J Thorac Cardiovasc Surg; 1989 Oct; 98(4):551-6. PubMed ID: 2796362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the effects of hypothermia on regional myocardial blood flow and metabolsim during cardiopulmonary bypass. II. Ischemia during moderate hypothermia in continually perfused beating hearts.
    McConnell DH; Brazier JR; Cooper N; Buckberg GD
    J Thorac Cardiovasc Surg; 1977 Jan; 73(1):95-101. PubMed ID: 831013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
    Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
    J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic myocardial protection. Comparison of nonoxygenated crystalloid, oxygenated crystalloid, and oxygenated fluorocarbon cardioplegic solutions.
    Tabayashi K; McKeown PP; Miyamoto M; Luedtke AE; Thomas R; Allen MD; Misbach GA; Ivey TD
    J Thorac Cardiovasc Surg; 1988 Feb; 95(2):239-46. PubMed ID: 3339891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial "equilibration processes" and myocardial energy turnover during initiation of artificial cardiac arrest with cardioplegic solution - reasons for a sufficiently long cardioplegic perfusion.
    Preusse CJ; Gebhard MM; Bretschneider HJ
    Thorac Cardiovasc Surg; 1981 Apr; 29(2):71-6. PubMed ID: 6166077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant N-(2-mercaptopropionyl)-glycine in blood cardioplegia does not improve myocardial protection in ischemically damaged hearts.
    Vinten-Johansen J; Chiantella V; Johnston WE; Jolly BT; Kendricks WD; Hester TO; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Jul; 100(1):65-76. PubMed ID: 2366567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.